drugset / Trial / NCT07829328

Can SAP P11-4 Affect The Appearance of Interproximal Cavities on an X-ray in a Military Population

NCT07829328 ↗

Phase 4 Enrolling by invitation 30 enrolled Tripler Army Medical Center
NaSingle-groupOpen-labelPrevention

Summary

The primary objective of the protocol is to learn about how SAP P 11-4 (produced commercially as Curodont products) can be used in a military population to treat incipient dental caries, or developing cavities that are still structurally intact and not too deep and increase awareness of the improvement and availability of minimally invasive treatment options for cavities in a military population.

Timeline

Start
2026-09-30
Primary completion
2027-02
Completion
2027-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject P11-4 Peptide — Topical
Subject sodium fluoride Unknown 0.05 % Topical